Omicron News and Research

RSS
Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

Omicron emergence in South Africa associated with increased reinfection risk, analysis finds

15 Mar 2022
Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

14 Mar 2022
Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

14 Mar 2022
Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

14 Mar 2022
Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

14 Mar 2022
Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

Neutralizing activity of therapeutic antibodies against clinical strains of BA.1 and BA.2 sub-lineages of the Omicron variant

14 Mar 2022
Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

Study shows the mutations leading to omicron variant did not help virus escape recognition by T cells

11 Mar 2022
Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

11 Mar 2022
Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

11 Mar 2022
Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

11 Mar 2022
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022
Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

11 Mar 2022
Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

10 Mar 2022
Three vaccine doses are crucial to achieve effective protection against omicron

Three vaccine doses are crucial to achieve effective protection against omicron

10 Mar 2022
Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

10 Mar 2022
Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

10 Mar 2022
Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

10 Mar 2022
Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

10 Mar 2022
Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

10 Mar 2022
WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

WVU researchers use machine learning and GIS to predict where COVID-19 testing will be most crucial

10 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback